NEW YORK, March 24, 2017 /PRNewswire/ --
The Healthcare sector is the category of stocks relating to medical andhealth care goods or services. It includes hospital management firms, health maintenance organizations, biotechnology, and a variety of medical products. Pre-market, Stock-Callers.com directs investors' attention to the following Healthcare stock: BioScrip
On Thursday, shares in Denver, Colorado-based BioScrip Inc. recorded a trading volume of 1.04 million shares. The stock ended flat at $1.77. The Company's shares have gained 9.26% in the last one month, 63.89% over the previous three months, and 70.19% on an YTD basis. The stock is trading above its 50-day moving average by 6.79%. Furthermore, shares of BioScrip, which provides home infusion services in the US, have a Relative Strength Index (RSI) of 48.92.
On March 03rd 2017, BioScrip announced its Q4 and full-year 2016 financial results. For Q4 2016, the Company reported revenue from continuing operations of $240.1 million, net loss from continuing operations of ($5.2) million, and diluted EPS of ($0.06) loss per share. For the full-year 2016, BioScrip reported revenue from continuing operations of $935.6 million, net loss from continuing operations of ($34.4) million, and diluted EPS of ($0.46) loss per share.
On March 06th, 2017, research firm Barrington Research reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $1.50 a share to $2.25 a share. Access our complete research report on BIOS for free at:
Community Health Systems
Franklin, Tennessee headquartered Community Health Systems Inc.'s stock finished yesterday's session 3.57% higher at $8.70. A total volume of 4.27 million shares was traded, which was above their three months average volume of 3.96 million shares. The Company's shares have surged 57.89% over the previous three months and 55.64% on an YTD basis. The stock is trading above its 50-day moving average by 11.82%. Furthermore, shares of Community Health Systems, which together with its subsidiaries, owns, leases, and operates general acute care hospitals in the US, have an RSI of 50.37.
On March 17th, 2017, Community Health Systems announced that its wholly-owned subsidiary, CHS/Community Health Systems, Inc., had completed its offering of $2.2 billion aggregate principal amount of its 6.250% Senior Secured Notes due 2023.
On March 01st, 2017, research firm Piper Jaffray downgraded the Company's stock rating from 'Neutral' to 'Underweight'. The complimentary research report on CYH can be downloaded at: http://stock-callers.com/registration/?symbol=CYH
At the close of trading on Thursday, shares in Dublin, Ireland headquartered Perrigo Co. PLC saw a slight decline of 0.39%, ending the day at $68.16. The stock recorded a trading volume of 875,327 shares. The Company's shares are trading 10.35% below their 50-day moving average. Moreover, shares of Perrigo, which together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide, have an RSI of 33.64.
On March 08th, 2017, Perrigo announced the first-to-market launch of the over-the-counter store brand equivalent to Women's Rogaine® 5% minoxidil foam (minoxidil topical aerosol, 5% foam). First shipments of this new store foam have already been initiated.
On March 03rd, 2017, research firm B. Riley & Co. reiterated its 'Neutral' rating on the Company's stock with a decrease of the target price from $83 a share to $67 a share. Register for free on Stock-Callers.com and get access to the latest PDF format report on PRGO at:
Health Insurance Innovations
Tampa, Florida-based Health Insurance Innovations Inc.'s shares ended the day 2.88% higher at $16.10 with a total trading volume of 216,263 shares. The stock has gained 17.95% over the previous three months. The Company's shares are trading 61.18% above their 200-day moving average. Additionally, shares of Health Insurance Innovations, which operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the US, have an RSI of 39.56.
On March 01st, 2017, Health Insurance Innovations announced financial results for Q4 and financial year ended December 31st, 2016. For 2016, revenue was $184.5 million, an increase of 76.2% over $104.7 million in 2015. Net income attributable to the Company was $4.5 million, adjusted EBITDA was $27.8 million, and GAAP diluted EPS was $0.57. Adjusted EPS was $1.12 in 2016 compared to $0.27 in 2015.
On March 13th, 2017, research firm Canaccord Genuity initiated a 'Buy' rating on the Company's stock, with a target price of $28 per share. Download your free research report on HIIQ at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Scientists design novel system that can turn on sensation of movement of missing arm, in persons ...
Dizziness is a feeling of being faint or unsteady whereas Vertigo is a feeling that you or your ...
Adult attention-deficit hyperactive disorder (ADHD) is a mental health condition in adults seen as ...View All